Travere Therapeutics TVTX
NASDAQ TVTX
$59.56 -0.43 (-0.72%)
As of: Sep 30, 2026 · 2:20 PM EDT

Travere Therapeutics (TVTX) Operating Expenses (2011 - 2026)

Updated

Travere Therapeutics (TVTX) recorded Operating Expenses of $165.63 million in Q2 2026, up 30.3% from $127.1 million a year earlier and up 0.9% from the prior quarter.

Analysis

Travere Therapeutics (TVTX) Operating Expenses (2011 - 2026) Analysis & Trends

On a TTM basis, Travere Therapeutics' Operating Expenses came in at $631.79 million as of Jun 30, 2026, up 24.8% year-over-year; for FY2025, it was $553.55 million, down 0.6% from FY2024.

  • Annual Operating Expenses has a five-year compound annual growth rate of 8.1% (FY2020 to FY2025).
  • Across earlier years, Operating Expenses came in at $557 million in FY2024 (+4.4%), $533.38 million in FY2023 (+24.3%), $429.27 million in FY2022 (+29.6%) and $331.26 million in FY2021 (-11.5%).
  • The Q2 2026 figure is the highest quarterly Operating Expenses since Q1 2024.
  • On a year-over-year basis, Operating Expenses has increased for five consecutive quarters, with growth averaging 7.7% over the last eight quarters.
  • Peak year-over-year performance for Operating Expenses in the last five years was growth of 149.8% in Q4 2022, against a decline of 72.6% in Q4 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $164.11 million (Q1 2026), $162.12 million (Q4 2025) and $139.93 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 10.12 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 10.56 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -9.70 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 2.09 Bn
10 Travere Therapeutics 5.65 Bn 5.25 Bn 167.41 Mn 165.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 165.63 Mn
Mar 31, 2026 164.11 Mn
Dec 31, 2025 162.12 Mn
Sep 30, 2025 139.93 Mn
Jun 30, 2025 127.10 Mn
Mar 31, 2025 124.41 Mn
Dec 31, 2024 135.52 Mn
Sep 30, 2024 119.05 Mn
Jun 30, 2024 121.82 Mn
Mar 31, 2024 180.61 Mn
Dec 31, 2023 139.29 Mn
Sep 30, 2023 129.68 Mn
Jun 30, 2023 136.15 Mn
Mar 31, 2023 128.26 Mn
Dec 31, 2022 116.04 Mn
Sep 30, 2022 110.68 Mn
Jun 30, 2022 107.16 Mn
Mar 31, 2022 95.39 Mn
Dec 31, 2021 46.45 Mn
Sep 30, 2021 99.93 Mn
API Access

Travere Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=TVTX&period=max&api_key=YOUR_API_KEY